Rare Diseases
Conference Coverage
AAN Finds That Medical Marijuana May Alleviate Certain MS Symptoms
News
Bevacizumab fails to improve survival in newly diagnosed glioblastoma
Major finding: Two similar studies found no difference in median survival with the addition of bevacizumab to standard therapy for patients with...
News
FDA approves droxidopa for neurogenic orthostatic hypotension
Conference Coverage
A Patient’s Path to Narcolepsy Diagnosis Is Frequently a Long and Winding Road
Conference Coverage
Brain–Computer Interfaces Could Aid Neurorehabilitation
Conference Coverage
New chemo regimen is active against recalcitrant neuroendocrine tumors
Major finding: The overall response rate was 43% and the clinical benefit rate was 97%. Data source: A randomized phase II trial among 28 patients...
News
Gene panel identifies residual neuroblastoma metastases
Major finding: In a multivariate analysis, patients negative for minimal residual disease had about a fourfold increased rate of progression-free...
Audio
Eva Feldman, MD, PhD
At the recent American Neurological Association annual meeting, Eva Feldman, MD, PhD, spoke about intraspinal stem cell injections for ALS.
Conference Coverage
Bilateral Stem Cell Injections Are Safe for Patients With ALS
News
CENTRIC results signal end of cilenglitide in glioblastoma
Major finding: Overall survival was 26.3 months in both study arms, and more events occurred in the cilenglitide arm than in the control arm (144...
Conference Coverage
Younger adults with brain metastases survive longer with radiosurgery alone
Major finding: Stereotactic radiosurgery was associated with significantly longer overall survival among patients age 50 years and younger (hazard...